Chemical Structure (Levetiracetam 01)
Levetiracetam Solution
Product Images NDC 0904-7265
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 0904-7265). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Levetiracetam 02)
Figure 2 (Levetiracetam 03)
The text provided is unclear and does not make sense. The numbers separated by percentage signs and the mixed alphanumeric characters do not provide any meaningful information. It is not possible to generate a useful description with this text.*
Figure 3 (Levetiracetam 04)
The given text is providing the percentage of patients for the Placebo and Levetiracetam groups based on the given dosage in a clinical trial. The information provided indicates that the Levetiracetam group was administered 3000 mg/day, and that the percentage of patients in that group was 39.4%. The Placebo group had a percentage of patients of 14.4%.*
Figure 4 (Levetiracetam 05)
This document contains data on the percentage of patients within a study's sample. The percentages shown are 4%, 10%, as%, a0%, 26%, 20%, 15%, 10%, %, and o%. Additionally, there are specific percentages for the placebo group (N=07) and the Levetiracetam group (N=101).*
Figure 5 (Levetiracetam 06)
The text appears to be a portion of a statistical report related to the comparison of a drug called "Levearacetzn" versus a placebo. The drug seems to have shown a statistically significant improvement in comparison to the placebo group, with a difference of 431%. However, it is not clear what the drug or the placebo are used for, or any other relevant details.*
Figure 6 (Levetiracetam 07)
Principal Display Panel (5 mL Cup Label)
This is a description of Levetiracetam, an oral solution medication produced by Major Pharmaceuticals. The medication is delivered in a 5 mL size, and is intended for institutional use only with a prescription. The package is not child-resistant. The label includes the NDC number, 0904-7265-41, and the manufacturer's location in Indianapolis, IN.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
